Stay up to date with the latest Avicenna.AI’s news, announcements, and milestones shaping our journey.
ChestCare: et si un seul scanner en révélait plus qu’on ne le pensait ?
Un scanner thoracique est prescrit pour une raison précise. Mais l’image contient souvent bien plus que ce pour quoi elle a été demandée, des signes cliniques qui, faute d’être systématiquement
Cervical Spine Fractures in Trauma: What a Missed Diagnosis Actually Means
KEY TAKEAWAYS A missed cervical spine fracture can turn into a neurological injury acquired during care, not at the time of the trauma. Delayed detection comes from the structural conditions
Vertebral Fractures: A Silent Epidemic That Medicine Is Still Failing to Diagnose
KEY TAKEAWAYS Only one in three vertebral fractures ever comes to clinical attention, and many fractures visible on existing CT scans are never reported. An undetected vertebral fracture is one
AI for Pulmonary Embolism: What 6 Peer-Reviewed Studies Actually Show
KEY TAKEAWAYS In a real-world study of 1,204 CTPA examinations, the rate of PE-positive cases not reported at first read fell from 15.6% to 3.8% after AI implementation. At a
Avicenna.AI and Bracco Imaging Announce Strategic Partnership
MILAN, March 2, 2026 – At the 2026 European Congress of Radiology (ECR), Bracco Imaging S.p.A., a global leader in diagnostic imaging, today announced a new strategic partnership with Avicenna.AI,
Avicenna.AI Joins Forces with Ferrum Health to Expand U.S. Access to Advanced Medical Imaging AI
KEY TAKEAWAYS Under the agreement, Ferrum will commercialize Avicenna.AI’s full portfolio of imaging AI solutions across the United States. The portfolio includes AI solutions for intracranial hemorrhage, large vessel occlusion,
Avicenna.AI Launches AVI: A Seamless Platform For Medical Imaging AI
KEY TAKEAWAYS AVI integrates directly with PACS and RIS without requiring additional viewers, worklists, or changes to clinical workflows. A one-time integration unlocks access to all applications on the platform,
Avicenna.AI Awarded European Funding to Accelerate Development of Its ChestCare Suite
Avicenna.AI is proud to announce it has been awarded funding under the “Provence-Alpes-Côte d’Azur and Massif des Alpes FEDER-FSE+-FTJ 2021–2027 program,” as part of the European Regional Development Fund (FEDER).
How AI is Changing Trauma Care?
KEY TAKEAWAYS Intracranial hemorrhage and cervical spine fractures are time-critical but can be subtle to detect on CT in a busy emergency department. CINA Trauma analyzes non-contrast CT scans in
Avicenna.AI Secures CE Mark for Two Spine Imaging AI Tools
KEY TAKEAWAYS Avicenna.AI received CE Mark certification for CINA-VCF Quantix and for CINA-CSpine. CINA-VCF Quantix calculates vertebral height loss ratios in the thoracic and lumbar spine and generates a passive
Emergency Radiology and the Critical Role of AI
KEY TAKEAWAYS Overcrowded hospitals, rising imaging volumes and a global shortage of radiologists have created a bottleneck in emergency care. AI flags life-threatening conditions such as stroke, pulmonary embolism and
KEY TAKEAWAYS RMS Medical Devices and Avicenna.AI have announced a strategic commercial partnership covering Belgium, the Netherlands, and Luxembourg. The first phase will focus on deploying Avicenna.AI’s solutions in key
KEY TAKEAWAYS Viz.ai is integrating Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into the Viz.ai One platform. CINA-ASPECTS assesses the ASPECTS score from CT brain images, and CINA-iPE detects incidental pulmonary embolism
KEY TAKEAWAYS TIM uses Avicenna.AI’s tools for systematic, near real-time analysis of CT exams, in both scheduled and emergency workflows. Over one month of activity, the AI generated 359 alerts:
TIM & AVICENNA.AI announce strategic partnership to strengthen medical imaging in France
KEY TAKEAWAYS TIM, a teleradiology player in mainland France and the French overseas territories, has strengthened its strategic partnership with Avicenna.AI. The partnership extends the use of Avicenna.AI’s artificial intelligence
Avicenna.AI lands FDA clearance for AI tool for cervical spine fracture detection
KEY TAKEAWAYS CINA-CSpine received FDA 510(k) clearance to support the detection and triage of cervical spine fractures from CT images. It was validated on more than 300 non-contrast CT scans
Avicenna.AI secures Medical Device Regulation certification for medical imaging AI portfolio
French AI company achieves key EU regulatory compliance for multiple algorithms that identify, detect, and quantify severe conditions from medical images.
Avicenna.AI secures FDA clearance for AI detection of vertebral compression fractures
Avicenna.AI receives approval for algorithms enabling incidental detection of pulmonary embolism and automatic assessment of stroke severity.
Avicenna.AI secures two FDA clearances for Stroke Assessment and opportunistic PE
Avicenna.AI receives approval for algorithms enabling incidental detection of pulmonary embolism and automatic assessment of stroke severity.
Blackford integrates CINA-iPE for opportunistic pulmonary embolism detection
KEY TAKEAWAYS Avicenna.AI’s CE-marked CINA-iPE is integrated into the Blackford AI Platform. Only 25% of incidental pulmonary emboli are reported during the initial interpretation of routine chest CT scans. Blackford
ConcertAI’s TeraRecon partners with Avicenna.AI for AI-driven chest care coordination.
KEY TAKEAWAYS Avicenna.AI’s FDA-cleared algorithms for pulmonary embolism and Type A and Type B aortic dissection integrate into TeraRecon’s Eureka Clinical AI platform. Upon detecting a PE or AD, the
How Artificial Intelligence is Revolutionizing Opportunistic Detection on CT scan?
In medical imaging, opportunistic findings are unexpected gems uncovered during unrelated procedures. The synergy of human expertise and AI’s pattern recognition becomes a powerful tool to speed up diagnoses, enhance care, and save lives.
ConcertAI’s TeraRecon and Avicenna.AI Partner on AI for Incidental Pulmonary Embolism
KEY TAKEAWAYS Avicenna.AI’s CE-marked CINA-iPE is offered as part of TeraRecon’s Eureka Clinical AI solution. Only 25% of incidental emboli are reported at the initial interpretation of routine chest CT
Avicenna.AI launches AI solution for incidental pulmonary embolism detection
Medical imaging company to introduce CINA-iPE – the first tool in its new AI suite for incidental findings – at ECR 2023. Marseille, FRANCE – February 22, 2023 – Medical
Avicenna.AI Lands Series A Funding to Fuel Global Growth, Bringing Total Investment to $10 Million
Medical imaging AI company brings total investment to $10 million and targets global growth.
Avicenna.AI partners with CARPL.ai on AI to detect life-threatening conditions
KEY TAKEAWAYS Avicenna.AI signed a distribution agreement with CARPL.ai, a platform for testing, validating and deploying AI applications. The CARPL platform now includes Avicenna.AI’s CINA solutions for neurovascular and thoraco-abdominal
Avicenna.AI collaborates with deepc to revolutionize Stroke Patient Care
KEY TAKEAWAYS Avicenna.AI’s full CINA stroke suite is now available through deepc’s radiology AI platform, deepcOS. The suite comprises two FDA-cleared, CE-marked triage tools, CINA-LVO and CINA-ICH, and one CE-marked
Avicenna.AI signs a distribution agreement with Sectra for neurovascular AI solutions
Avicenna.AI signs a distribution agreement with Sectra for neurovascular AI solutions
Avicenna.AI partners UpCare for innovative value-based solutions to Canadian health providers
Avicenna.AI Partners With UpCare To Deliver Innovative Value-Based Solution to Canadian Health Providers
Viz.ai and Avicenna.AI Launch AI Care for Pulmonary Embolism & Aortic Disease
Viz.ai and Avicenna.AI Partner to Launch World-class AI-Driven Intelligent Care Coordination for Pulmonary Embolism and Aortic Disease
Avicenna.AI Joins Nuance AI Marketplace, Offering Cutting-Edge Solutions for Diagnostic Imaging
Avicenna.AI Joins Nuance AI Marketplace for Diagnostic Imaging for Stroke tools
AI triage solution for deadly vascular conditions receives FDA clearance and CE Marking
AI triage solution for Pulmonary Embolism and Aortic Dissection receives FDA clearance and CE Mark
Avicenna.AI receives CE Mark for stroke severity assessment AI tool
Avicenna.AI receives CE Mark for Automatic ASPECT Scoring AI tool
Arterys & Avicenna.AI Join Forces on AI Stroke Detection
Arterys partners with Avicenna.AI on AI Stroke Detection
Stroke Detection AI Tool Approved for Medicare NTAP
Stroke Detection AI Tool Approved for Medicare NTAP
Avicenna.AI Partners With Canon Medical on AI Stroke Detection
KEY TAKEAWAYS Avicenna.AI partnered with Canon Medical Systems Corporation to deliver a fully integrated stroke detection AI solution for Canon’s Automation Platform. CINA Head detects intracranial hemorrhage (ICH) and large
The Steps to Build a Robust Clinical Application
KEY TAKEAWAYS Before the actual validation starts, three preliminary steps are carried out: bibliographical research, writing the validation protocol, and constituting the database. Performance is calculated on all the data
Surging AI in Healthcare: What Sets Avicenna.AI’s Triage Apart?
KEY TAKEAWAYS A key focus of the Avicenna portfolio is emergency triage, where AI helps identify patients with positive, urgent findings that need to be addressed promptly. All findings made
Daniel Chow’s Interview: A Radiologist’s Journey from UCLA to AI Leadership
KEY TAKEAWAYS In the short term, Daniel Chow expects AI to take on tedious day-to-day tasks such as measuring and following lesions. He looks for tools that involve minimal clicks,
Dr. Jennifer Soun: Neuroscience to Radiology – Advancing AI in Clinical Practice
Dr. Soun is a board-certified UCI Health diagnostic radiologist who specializes in neuroradiology. Her clinical interests include stroke and vascular imaging.
Avicenna.AI secures FDA clearance for its CINA neurovascular imaging Tool
KEY TAKEAWAYS Avicenna.AI received 510(k) clearance from the US Food and Drug Administration for its CINA triage AI solution for neurovascular emergencies. The clearance covers automatic detection of both intracranial
Sur le marché de la radiologie, Avicenna.AI se place en challenger
Installée à La Ciotat, cette entreprise offre aux radiologues un outil leur permettant de déterminer quels patients nécessitent une prise en charge d’urgence grâce à l’intelligence artificielle. Après avoir pris le temps de perfectionner sa solution, elle s’apprête à la mettre sur le marché et vise avant tout les États-Unis.
Avicenna.AI completes its first round of financing for 2.7 million dollars
KEY TAKEAWAYS Avicenna.AI completed its first capital increase with Innovacom and CEMAG Invest. Avicenna.AI develops algorithms dedicated to the detection of life threatening lesions, helping specialists identify faster the patients
Tell us about your challenges and clinical routine. We will show you which CINA tools fit, and how they plug into your PACS.
Get the latest updates and insights from Avicenna.AI.
